Jiangsu gdk Biotechnology Co Ltd - Class A

SHSE:688670 (China)   Class A
Â¥ 13.85 (+3.67%) Jun 7
At Loss
P/B:
1.26
Market Cap:
Â¥ 1.71B ($ 235.43M)
Enterprise V:
Â¥ 1.56B ($ 215.91M)
Volume:
834.54K
Avg Vol (2M):
611.53K
Volume:
834.54K
At Loss
Avg Vol (2M):
611.53K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Jiangsu gdk Biotechnology Co Ltd ( ) from 2021 to Jun 10 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Jiangsu gdk Biotechnology stock (SHSE:688670) PE ratio as of Jun 10 2024 is 0. More Details

Jiangsu gdk Biotechnology Co Ltd (SHSE:688670) PE Ratio (TTM) Chart

To

Jiangsu gdk Biotechnology Co Ltd (SHSE:688670) PE Ratio (TTM) Historical Data

Total 691
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 8
Jiangsu gdk Biotechnology PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-10 At Loss 2024-04-01 At Loss
2024-06-07 At Loss 2024-03-29 At Loss
2024-06-06 At Loss 2024-03-28 At Loss
2024-06-05 At Loss 2024-03-27 At Loss
2024-06-04 At Loss 2024-03-26 At Loss
2024-06-03 At Loss 2024-03-25 At Loss
2024-05-31 At Loss 2024-03-22 At Loss
2024-05-30 At Loss 2024-03-21 At Loss
2024-05-29 At Loss 2024-03-20 At Loss
2024-05-28 At Loss 2024-03-19 At Loss
2024-05-27 At Loss 2024-03-18 At Loss
2024-05-24 At Loss 2024-03-15 At Loss
2024-05-23 At Loss 2024-03-14 At Loss
2024-05-22 At Loss 2024-03-13 At Loss
2024-05-21 At Loss 2024-03-12 At Loss
2024-05-20 At Loss 2024-03-11 At Loss
2024-05-17 At Loss 2024-03-08 At Loss
2024-05-16 At Loss 2024-03-07 At Loss
2024-05-15 At Loss 2024-03-06 At Loss
2024-05-14 At Loss 2024-03-05 At Loss
2024-05-13 At Loss 2024-03-04 At Loss
2024-05-10 At Loss 2024-03-01 At Loss
2024-05-09 At Loss 2024-02-29 At Loss
2024-05-08 At Loss 2024-02-28 At Loss
2024-05-07 At Loss 2024-02-27 At Loss
2024-05-06 At Loss 2024-02-26 At Loss
2024-04-30 At Loss 2024-02-23 At Loss
2024-04-29 At Loss 2024-02-22 At Loss
2024-04-26 At Loss 2024-02-21 At Loss
2024-04-25 At Loss 2024-02-20 At Loss
2024-04-24 At Loss 2024-02-19 At Loss
2024-04-23 At Loss 2024-02-08 At Loss
2024-04-22 At Loss 2024-02-07 At Loss
2024-04-19 At Loss 2024-02-06 At Loss
2024-04-18 At Loss 2024-02-05 At Loss
2024-04-17 At Loss 2024-02-02 At Loss
2024-04-16 At Loss 2024-02-01 At Loss
2024-04-15 At Loss 2024-01-31 At Loss
2024-04-12 At Loss 2024-01-30 At Loss
2024-04-11 At Loss 2024-01-29 At Loss
2024-04-10 At Loss 2024-01-26 At Loss
2024-04-09 At Loss 2024-01-25 At Loss
2024-04-08 At Loss 2024-01-24 At Loss
2024-04-03 At Loss 2024-01-23 At Loss
2024-04-02 At Loss 2024-01-22 At Loss

Jiangsu gdk Biotechnology Co Ltd (SHSE:688670) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Jiangsu gdk Biotechnology Co Ltd is a biological high-tech enterprise integrating scientific research, production, operation and service of human vaccines. The company's product pipeline covers prevention of five important infectious diseases such as influenza, rabies, chickenpox, shingles and pneumonia.